{"id":1006506,"date":"2026-09-29T07:57:34","date_gmt":"2026-09-29T11:57:34","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-october-investor-and-industry-conferences\/"},"modified":"2026-09-29T07:57:34","modified_gmt":"2026-09-29T11:57:34","slug":"ocugen-to-participate-in-upcoming-october-investor-and-industry-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-october-investor-and-industry-conferences\/","title":{"rendered":"Ocugen to Participate in Upcoming October Investor and Industry Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>MALVERN, Pa., Sept.  29, 2026  (GLOBE NEWSWIRE) &#8212; Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology company developing gene therapies for blindness diseases, today announced that members of its executive leadership team will present at two upcoming investor and industry conferences.<\/p>\n<p>\n        <strong><br \/>\n          <u>H.C. Wainwright: Biotech on Tap 2026<\/u><br \/>\n        <\/strong><br \/>\n        <br \/>\n        <strong>Location: <\/strong>EY Auditorium, Munich, Germany<br \/><strong>Date:<\/strong> Thursday, October 1, 2026<br \/><strong>Time:<\/strong> 1:45\u20132:30 p.m. CEST<br \/><strong>Format:<\/strong> Panel discussion<br \/><strong>Title:<\/strong> Structured Finance Solutions: Royalty, Credit and Other Alternative Financing Options for Life Sciences<br \/><strong>Presenter:<\/strong> Session Moderator \u2014 Dr. Shankar Musunuri, Chairman, CEO, and Co-Founder, Ocugen<\/p>\n<p>\n        <strong><br \/>\n          <u>Cell &amp; Gene Meeting on the Mesa 2026<\/u><br \/>\n        <\/strong><br \/>\n        <br \/>\n        <strong>Location: <\/strong>Arizona Biltmore, Phoenix, AZ<br \/><strong>Date:<\/strong> Tuesday, October 6, 2026<br \/><strong>Time:<\/strong> 2:15\u20133:15 p.m. MST<br \/><strong>Format:<\/strong> Panel discussion<br \/><strong>Title:<\/strong> Navigating the Road to Approval, Commercialization, and the Future of Cell and Gene Therapy<br \/><strong>Presenter:<\/strong> Dr. Shankar Musunuri, Chairman, CEO, and Co-Founder, Ocugen<\/p>\n<p>\n        <strong>About Ocugen, Inc.<\/strong><br \/>\n        <br \/>Ocugen, Inc. is a pioneering biotechnology company developing gene therapies for blindness diseases. The Company\u2019s breakthrough modifier gene therapy platform has the potential to address significant unmet medical needs across large patient populations through a gene-agnostic approach. Unlike traditional gene therapies and gene-editing technologies that target a single gene mutation, Ocugen\u2019s modifier gene therapies are designed to address the underlying disease biology by restoring balance across multiple gene networks. The Company is currently advancing programs for inherited retinal diseases and other causes of blindness that affect millions worldwide, including retinitis pigmentosa, Stargardt disease, and geographic atrophy, an advanced form of dry age-related macular degeneration. Discover more at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=M9roQpGBNO2ky-GB7pWm9nMMeJphTS6e94TRPGF2GBhTuEitC_1WtbSyzKKxRuWlaThEKOReq-LflsCbB4llNQ==\" rel=\"nofollow\" target=\"_blank\">www.ocugen.com<\/a> and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nm6tD7JwObAjH99a49t46G6-plkLyt065oChocmSbIv2cM9VB53vVQYnlLFU5AZtb-AkyaVC5yjalvhgWleC5JvqEWvVuOSFwfaMtbeYQeY=\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KqCGO52Jt-fXkw0SJcsBoN6IH5pzpdYv9Dx2A81tZhBazvnJsmjVAiynwUm5mzgl\" rel=\"nofollow\" target=\"_blank\">X<\/a>.<\/p>\n<p><strong>Cautionary Note on Forward-Looking Statements<\/strong><br \/>This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties. We may, in some cases, use terms such as \u201cpredicts,\u201d \u201cbelieves,\u201d \u201cpotential,\u201d \u201cproposed,\u201d \u201ccontinue,\u201d \u201cestimates,\u201d \u201canticipates,\u201d \u201cexpects,\u201d \u201cplans,\u201d \u201cintends,\u201d \u201cmay,\u201d \u201ccould,\u201d \u201cmight,\u201d \u201cwill,\u201d \u201cshould,\u201d or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. Such statements are subject to numerous important factors, risks, and uncertainties that may cause actual events or results to differ materially from our current expectations. These and other risks and uncertainties are more fully described in our filings with the Securities and Exchange Commission (SEC), including the risk factors described in the section entitled \u201cRisk Factors\u201d in the quarterly and annual reports that we file with the SEC. Any forward-looking statements that we make in this press release speak only as of the date of this press release. Except as required by law, we assume no obligation to update forward-looking statements contained in this press release whether as a result of new information, future events, or otherwise, after the date of this press release.<\/p>\n<p>\n        <strong>Contacts<\/strong>:<\/p>\n<p>Investors:<br \/>Candice Masse<br \/>astr partners<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nSPuwCsO0rN6uOEAL_XyBYpNnkSHEUeBMctzrJtKpDYTlI9WrgQ-CIKtT3sFVbHlCEs3O0Ip2sfRwLEHYy7_Wke-i-2QS06fU91jzBK9XuUK784PupalHZsL6dDeBg97\" rel=\"nofollow\" target=\"_blank\">candice.masse@astrpartners.com<\/a><\/p>\n<p>Media:<br \/>Chris Clark<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SbK-xwNnE0y1SGYtBmW0QXK6U_Mf9EhCH0jc0Xxkm94qzT5-ufTvKxfGJaF96cXoP3m6YYu18v106cAAc7GAjn04D16-JE1G4IhP6-WhR8I=\" rel=\"nofollow\" target=\"_blank\">chris.clark@ocugen.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNTQ3NSM3ODY3OTIzIzIxODQ1MTk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YzgzZTA1MTEtM2UwYi00Y2EzLTg4ZmYtNjc2NjIxNDc2NjZhLTExOTYwNzMtMjAyNi0wOS0yOS1lbg==\/tiny\/Ocugen.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MALVERN, Pa., Sept. 29, 2026 (GLOBE NEWSWIRE) &#8212; Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology company developing gene therapies for blindness diseases, today announced that members of its executive leadership team will present at two upcoming investor and industry conferences. H.C. Wainwright: Biotech on Tap 2026 Location: EY Auditorium, Munich, GermanyDate: Thursday, October 1, 2026Time: 1:45\u20132:30 p.m. CESTFormat: Panel discussionTitle: Structured Finance Solutions: Royalty, Credit and Other Alternative Financing Options for Life SciencesPresenter: Session Moderator \u2014 Dr. Shankar Musunuri, Chairman, CEO, and Co-Founder, Ocugen Cell &amp; Gene Meeting on the Mesa 2026 Location: Arizona Biltmore, Phoenix, AZDate: Tuesday, October 6, 2026Time: 2:15\u20133:15 p.m. MSTFormat: Panel discussionTitle: Navigating the Road to Approval, Commercialization, and the Future of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-october-investor-and-industry-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Ocugen to Participate in Upcoming October Investor and Industry Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1006506","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ocugen to Participate in Upcoming October Investor and Industry Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-october-investor-and-industry-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ocugen to Participate in Upcoming October Investor and Industry Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MALVERN, Pa., Sept. 29, 2026 (GLOBE NEWSWIRE) &#8212; Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology company developing gene therapies for blindness diseases, today announced that members of its executive leadership team will present at two upcoming investor and industry conferences. H.C. Wainwright: Biotech on Tap 2026 Location: EY Auditorium, Munich, GermanyDate: Thursday, October 1, 2026Time: 1:45\u20132:30 p.m. CESTFormat: Panel discussionTitle: Structured Finance Solutions: Royalty, Credit and Other Alternative Financing Options for Life SciencesPresenter: Session Moderator \u2014 Dr. Shankar Musunuri, Chairman, CEO, and Co-Founder, Ocugen Cell &amp; Gene Meeting on the Mesa 2026 Location: Arizona Biltmore, Phoenix, AZDate: Tuesday, October 6, 2026Time: 2:15\u20133:15 p.m. MSTFormat: Panel discussionTitle: Navigating the Road to Approval, Commercialization, and the Future of &hellip; Continue reading &quot;Ocugen to Participate in Upcoming October Investor and Industry Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-october-investor-and-industry-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-29T11:57:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNTQ3NSM3ODY3OTIzIzIxODQ1MTk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-october-investor-and-industry-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-october-investor-and-industry-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Ocugen to Participate in Upcoming October Investor and Industry Conferences\",\"datePublished\":\"2026-09-29T11:57:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-october-investor-and-industry-conferences\\\/\"},\"wordCount\":475,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-october-investor-and-industry-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgzNTQ3NSM3ODY3OTIzIzIxODQ1MTk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-october-investor-and-industry-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-october-investor-and-industry-conferences\\\/\",\"name\":\"Ocugen to Participate in Upcoming October Investor and Industry Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-october-investor-and-industry-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-october-investor-and-industry-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgzNTQ3NSM3ODY3OTIzIzIxODQ1MTk=\",\"datePublished\":\"2026-09-29T11:57:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-october-investor-and-industry-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-october-investor-and-industry-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-october-investor-and-industry-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgzNTQ3NSM3ODY3OTIzIzIxODQ1MTk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgzNTQ3NSM3ODY3OTIzIzIxODQ1MTk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-october-investor-and-industry-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ocugen to Participate in Upcoming October Investor and Industry Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ocugen to Participate in Upcoming October Investor and Industry Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-october-investor-and-industry-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Ocugen to Participate in Upcoming October Investor and Industry Conferences - Market Newsdesk","og_description":"MALVERN, Pa., Sept. 29, 2026 (GLOBE NEWSWIRE) &#8212; Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology company developing gene therapies for blindness diseases, today announced that members of its executive leadership team will present at two upcoming investor and industry conferences. H.C. Wainwright: Biotech on Tap 2026 Location: EY Auditorium, Munich, GermanyDate: Thursday, October 1, 2026Time: 1:45\u20132:30 p.m. CESTFormat: Panel discussionTitle: Structured Finance Solutions: Royalty, Credit and Other Alternative Financing Options for Life SciencesPresenter: Session Moderator \u2014 Dr. Shankar Musunuri, Chairman, CEO, and Co-Founder, Ocugen Cell &amp; Gene Meeting on the Mesa 2026 Location: Arizona Biltmore, Phoenix, AZDate: Tuesday, October 6, 2026Time: 2:15\u20133:15 p.m. MSTFormat: Panel discussionTitle: Navigating the Road to Approval, Commercialization, and the Future of &hellip; Continue reading \"Ocugen to Participate in Upcoming October Investor and Industry Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-october-investor-and-industry-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-09-29T11:57:34+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNTQ3NSM3ODY3OTIzIzIxODQ1MTk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-october-investor-and-industry-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-october-investor-and-industry-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Ocugen to Participate in Upcoming October Investor and Industry Conferences","datePublished":"2026-09-29T11:57:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-october-investor-and-industry-conferences\/"},"wordCount":475,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-october-investor-and-industry-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNTQ3NSM3ODY3OTIzIzIxODQ1MTk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-october-investor-and-industry-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-october-investor-and-industry-conferences\/","name":"Ocugen to Participate in Upcoming October Investor and Industry Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-october-investor-and-industry-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-october-investor-and-industry-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNTQ3NSM3ODY3OTIzIzIxODQ1MTk=","datePublished":"2026-09-29T11:57:34+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-october-investor-and-industry-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-october-investor-and-industry-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-october-investor-and-industry-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNTQ3NSM3ODY3OTIzIzIxODQ1MTk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNTQ3NSM3ODY3OTIzIzIxODQ1MTk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-october-investor-and-industry-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Ocugen to Participate in Upcoming October Investor and Industry Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1006506","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1006506"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1006506\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1006506"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1006506"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1006506"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}